Logo image
Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma
期刊文章   同儕審查

Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma

Fong-I.N. Chou, Wing-Yiu Lui, Yuan-Yaw Wei, Ren-Jei Chung, Ji-Jung KaiChin-Wen Chi
Anticancer Research, 卷.19(3 A), 頁碼.1759-1764
1999
PMID: 10470112

摘要

B-lipiodol Hepatoma Neutron capture therapy Oncology Cancer Research
Background: We prepared boron containing lipiodol (B-lipiodol), elucidated the retention of B-lipiodol in hepatoma cells and evaluated the in vitro cellular toxicity of B-lipiodol for neuron capture therapy. Material and Methods: Human hepatoma HepG2 cells were used to examine the uptake and retention of B-lipiodol. Light microscopes were used to examine the interaction and retention of B-lipiodol concentrations were determined by inductively coupled plasma-atomic emission spectroscopy and neutron activation analysis, respectively. Results: The boron concentration in B-lipiodol drug could reach 2500 ppm. B-lipiodol could be stably retained in serum and culture medium. HepG2 cells appeared proficiently at internalization and persistent retention of B-lipiodol. The boron concentration reached 3.5 μg/10 6 cells without approaching saturation at 48 h treatment. Conclusion: Hepatoma cells could actively uptake B-lipiodol and a sufficient amount of boron was retained inside the HepG2 cells which could be used for neutron capture therapy.

相關連結

指標

1 檢視次數

詳細資料

Logo image